New York City has emerged as one of the epicenters of the SARS-COV-2 pandemic, with the Bronx being disproportionately affected. This novel coronavirus has caused significant respiratory manifestations raising the concern for development of acute chest syndrome (ACS) in patients with sickle cell disease (SCD). We report a series of pediatric SCD SARS-COV-2-positive patients admitted with ACS. SARS-COV-2-positive SCD patients, who did not develop ACS, were the comparison group. Hydroxyurea use (P-value = .02) and lower absolute monocyte counts (P-value = .04) were noted in patients who did not develop ACS. These preliminary findings need to be further evaluated in larger cohorts.

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.28579DOI Listing

Publication Analysis

Top Keywords

acute chest
8
chest syndrome
8
patients develop
8
develop acs
8
syndrome setting
4
setting sars-cov-2
4
sars-cov-2 infections-a
4
infections-a case
4
case series
4
series urban
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!